Growth of molecular diagnostics and genetic testing in the USA, 2008-2011: analysis and implications.

Aims: Advances in genomics and molecular diagnostic testing are expanding, but national data on which to base clinical, regulatory and reimbursement policies in the USA are lacking. The study objective is to provide current estimates of utilization/spending trends for private and public payers.

Patients & Methods: Healthcare utilization/expenditure claims data for 32 million individuals across the USA in 2008-2011 were analyzed.